Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Key failure to deliver metrics for Quest Diagnostics
Last SEC data release: 2023-10-31
Last 15 days FTD volume: $0.14 M
Last 3 months FTD volume: $4.56 M
Last year FTD volume: $51.58 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations.
FTDs for US listed companies are reported to the SEC and published twice a month.
Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Quest Diagnostics
(DGX) - 3 month history
Number of shares, 3 month chart
Biweekly Failures to deliver volume for Quest Diagnostics
(DGX) - since 2013
Volume in USD (price x number of shares), data since 2013
(DGX) Failure to deliver volume, Year over Year
Volume (Price x Shares)
FTD volume in the last 3 months for similar companies or competitors
The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.
CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.
For inquiries or if you want to report a problem write to helnospamlo@8market(nospam)cap.com